Australia markets closed

Sansure Biotech Inc. (688289.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
19.07+0.27 (+1.44%)
At close: 03:00PM CST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
3,014,667
6,450,357
4,514,539
4,762,964
Cost of revenue
1,199,489
2,655,368
1,279,045
969,953
Gross profit
1,815,178
3,794,989
3,235,494
3,793,011
Operating expenses
Research development
289,181
331,834
187,504
82,771
Selling general and administrative
747,606
834,860
434,897
558,532
Total operating expenses
1,079,672
1,262,150
666,900
680,876
Operating income or loss
735,505
2,532,839
2,568,594
3,112,135
Interest expense
2,340
2,091
829.4117
508.1667
Income before tax
796,893
2,315,922
2,616,205
3,070,161
Income tax expense
160,032
379,215
373,682
453,564
Income from continuing operations
636,861
1,936,707
2,242,524
2,616,597
Net income
638,156
1,936,801
2,242,696
2,616,597
Net income available to common shareholders
638,156
1,936,801
2,242,696
2,616,597
Basic EPS
1.08
3.31
3.81
4.74
Diluted EPS
1.08
3.31
3.81
4.74
Basic average shares
588,397
585,136
588,634
552,434
Diluted average shares
588,397
585,136
588,634
552,434